Catabasis Pharmaceuticals Inc buy melinda
Start price
04.10.17
/
50%
€188.33
Target price
19.12.17
€270.60
Performance (%)
-53.02%
End price
19.12.17
€88.49
Summary
This prediction ended on 19.12.17 with a price of €88.49. The BUY prediction by melinda for Catabasis Pharmaceuticals Inc performed very badly with a performance of -53.02%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Catabasis Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by melinda for this prediction
In the thread Catabasis Pharmaceuticals Inc diskutieren
CATB Catabasis Pharmaceuticals Inc.
Front-Line - Daten der Phase 2 Phase 1/2 31. Januar veröffentlicht, 2017 - nicht den Endpunkt erreicht. Teil C, offene Daten am 4. Oktober 2017 auf dem Internationalen Kongress der Welt Muscle Society.
(Vom Mitglied beendet)
Stopped prediction by melinda for Catabasis Pharmaceuticals Inc
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.84
27.10.20
27.10.20
€15.00
04.11.21
04.11.21
-20.00%
05.11.21
05.11.21
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€29.28
03.03.20
03.03.20
€33.00
27.10.20
27.10.20
-69.82%
27.10.20
27.10.20
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€67.65
02.02.17
02.02.17
€108.24
10.03.17
10.03.17
68.84%
10.03.17
10.03.17
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€188.34
16.12.16
16.12.16
€216.48
22.12.16
22.12.16
18.10%
22.12.16
22.12.16
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€196.46
10.07.16
10.07.16
€270.60
04.08.16
04.08.16
39.97%
04.08.16
04.08.16